Announcement on Initiation of Phase II Clinical Trial of ARX305

About this update from Zhejiang Medicine Co., Ltd. Class A

Announcement on Initiation of Phase II Clinical Trial of ARX305 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Medicine Co., Ltd. Class A